A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy
Stephen R. D. Johnston, Vladimir F. Semiglazov, George M. Manikhas, Dominique Spaeth, Gilles Romieu, David J. Dodwell, Andrew M. Wardley, Patrick Neven, Annick Bessems, Youn C. Park, Peter M. De PorreVolume:
110
Langue:
english
Pages:
9
DOI:
10.1007/s10549-007-9726-1
Date:
July, 2008
Fichier:
PDF, 180 KB
english, 2008